Inflammation, oxidative stress, and atherosclerosis.
Le
Ngoc-Anh
NA
D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism; D018797:Cell Cycle Proteins; D002986:Clinical Trials as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007249:Inflammation / Q000150:complications*; D050356:Lipid Metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D018384:Oxidative Stress; D020648:Peptide Elongation Factor 1; D011506:Proteins / Q000378:metabolism / Q000494:pharmacology
D018797:Cell Cycle Proteins; C503234:EEF1A2 protein, human; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020648:Peptide Elongation Factor 1; D011506:Proteins; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III